Oxford Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-39,842
| Closed | -$35K | – | 791 |
|
|
2019
Q4 | $35K | Sell |
39,842
-110,822
| -74% | -$97.4K | ﹤0.01% | 1679 |
|
|
2019
Q3 | $148K | Buy |
150,664
+17,851
| +13% | +$17.5K | ﹤0.01% | 1600 |
|
|
2019
Q2 | $146K | Sell |
132,813
-28,465
| -18% | -$31.3K | ﹤0.01% | 1587 |
|
|
2019
Q1 | $211K | Buy |
161,278
+45,869
| +40% | +$60K | ﹤0.01% | 1493 |
|
|
2018
Q4 | $105K | Buy |
+115,409
| New | +$105K | ﹤0.01% | 1644 |
|
|
2017
Q2 | – | Sell |
-16,822
| Closed | -$51K | – | 1593 |
|
|
2017
Q1 | $51K | Buy |
+16,822
| New | +$51K | ﹤0.01% | 1372 |
|
|
2015
Q3 | – | Sell |
-140,390
| Closed | -$411K | – | 678 |
|
|
2015
Q2 | $411K | Buy |
+140,390
| New | +$411K | 0.01% | 547 |
|